Noriomi Matsumura Selected Research

Noriomi Matsumura Research Topics

Disease

64	Neoplasms (Cancer) 09/2022 - 03/2006
41	Ovarian Neoplasms (Ovarian Cancer) 07/2022 - 02/2007
15	Carcinoma (Carcinomatosis) 01/2022 - 12/2010
9	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2022 - 01/2007
9	Endometrial Neoplasms (Endometrial Cancer) 06/2022 - 04/2011
7	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2010
7	Carcinogenesis 01/2020 - 03/2006
5	Endometriosis 11/2021 - 01/2015
5	Cysts 10/2020 - 01/2014
5	Ovarian Epithelial Carcinoma 01/2020 - 02/2007
3	Leiomyoma (Uterine Fibroids) 01/2021 - 11/2003
2	Papillomavirus Infections 12/2022 - 04/2022
2	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 02/2011
2	Residual Neoplasm 06/2022 - 03/2012
2	Leiomyosarcoma 01/2022 - 03/2006
2	Myoma 04/2020 - 02/2018
2	Hypoxia (Hypoxemia) 01/2020 - 09/2015
2	Granulosa Cell Tumor 11/2019 - 07/2017
2	Pre-Eclampsia (Preeclampsia) 05/2019 - 01/2019
2	Vomiting 02/2017 - 04/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2015 - 05/2014
2	Anemia 01/2014 - 12/2010
1	Infections 12/2022
1	Uterine Cervical Dysplasia 12/2022
1	Adenomyosis 12/2021
1	Pelvic Organ Prolapse 10/2021
1	Ovarian Cysts (Ovarian Cyst) 04/2021
1	Hemorrhage 04/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Hematuria 01/2021

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 01/2022 - 08/2007
8	Cisplatin (Platino)FDA LinkGeneric 11/2021 - 08/2007
8	LigandsIBA 01/2021 - 05/2009
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2007
6	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2016
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 05/2010
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2022 - 01/2021
5	Pharmaceutical PreparationsIBA 07/2022 - 01/2007
5	Proteins (Proteins, Gene)FDA Link 05/2018 - 11/2003
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2022 - 06/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2009
4	IronIBA 06/2020 - 01/2014
4	taxaneIBA 01/2019 - 02/2009
4	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2010
3	Papillomavirus Vaccines (HPV Vaccines)IBA 12/2022 - 01/2021
3	NivolumabIBA 01/2021 - 12/2015
3	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2009
3	B7-H1 AntigenIBA 01/2016 - 03/2013
3	Biological ProductsIBA 10/2015 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 10/2015 - 02/2010
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2015 - 01/2011
3	Messenger RNA (mRNA)IBA 02/2010 - 11/2003
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2022 - 03/2012
2	Bevacizumab (Avastin)FDA Link 07/2022 - 06/2022
2	niraparibIBA 06/2022 - 01/2022
2	ChemokinesIBA 01/2021 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 07/2017
2	Fetal Proteins (Fetoprotein)IBA 01/2021 - 12/2010
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2015
2	7-hydroxystaurosporine (UCN 01)IBA 01/2021 - 05/2010
2	Therapeutic UsesIBA 01/2019 - 01/2010
2	AntibodiesIBA 01/2017 - 06/2016
2	Irinotecan (Camptosar)FDA LinkGeneric 04/2016 - 10/2015
2	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 01/2015
2	KisspeptinsIBA 06/2015 - 04/2011
2	Sorafenib (BAY 43-9006)FDA Link 01/2014 - 12/2010
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2012 - 12/2011
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 12/2011 - 03/2009
2	ProgranulinsIBA 02/2007 - 03/2006
2	Complementary DNA (cDNA)IBA 03/2006 - 11/2003
1	VaccinesIBA 12/2022
1	1- nitro- 9- (2- dihydroxyethylaminoethylamino)acridine (C 835)IBA 09/2022
1	Cytostatic AgentsIBA 07/2022
1	olaparibIBA 06/2022
1	Poly Adenosine Diphosphate RiboseIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 11/2021
1	ParaffinIBA 11/2021
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2021
1	AsbestosIBA 01/2021
1	Protein Kinase CIBA 01/2021
1	oltiprazIBA 01/2021
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2021

Therapy/Procedure

26	Drug Therapy (Chemotherapy) 07/2022 - 02/2009
17	Therapeutics 06/2022 - 02/2010
9	Hysterectomy 06/2022 - 11/2013
7	Neoadjuvant Therapy 01/2020 - 05/2014
5	Immunotherapy 01/2022 - 02/2008
4	Lymph Node Excision (Lymph Node Dissection) 10/2020 - 01/2014
4	Radiotherapy 11/2018 - 04/2016
3	Salpingo-oophorectomy 08/2016 - 11/2013
2	Blood Transfusion (Blood Transfusions) 04/2021 - 07/2019
2	Uterine Myomectomy 04/2020 - 02/2018
2	Cesarean Section (Caesarean Section) 01/2017 - 12/2010
1	Conservative Treatment 12/2021
1	Lasers (Laser) 11/2021
1	Operative Surgical Procedures 10/2021
1	Cystectomy 04/2021
1	Sutures (Suture) 04/2021
1	Nephrotomy 01/2021